Atlas Capital Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.5K	Hold	905	–	–	﹤0.01%	697
2025 Q4	$31.5K	Buy	+905	New	+$71.1K	﹤0.01%	684
2025 Q2	$66.4K	Sell	905 -10,000	-92%	-$725K	0.01%	589
2025 Q1	$1.25M	Hold	10,905	–	–	0.16%	117
2024 Q4	$550K	Buy	+10,905	New	+$571K	0.07%	217
2024 Q3	–	Sell	-10,905	Closed	-$354K	–	916
2024 Q2	$354K	Buy	+10,905	New	+$299K	0.05%	295
2024 Q1	–	Sell	-10,905	Closed	-$354K	–	903
2023 Q4	$354K	Hold	10,905	–	–	0.05%	273
2023 Q3	$297K	Hold	10,905	–	–	0.05%	281
2023 Q2	$243K	Hold	10,905	–	–	0.04%	328
2023 Q1	$236K	Hold	10,905	–	–	0.04%	330
2022 Q4	$221K	Hold	10,905	–	–	0.04%	323
2022 Q3	$280K	Hold	10,905	–	–	0.05%	277
2022 Q2	$259K	Hold	10,905	–	–	0.04%	317
2022 Q1	$246K	Hold	10,905	–	–	0.04%	319
2021 Q4	$216K	Hold	10,905	–	–	0.03%	344
2021 Q3	$215K	Hold	10,905	–	–	0.03%	334
2021 Q2	$240K	Hold	10,905	–	–	0.04%	330
2021 Q1	$259K	Hold	10,905	–	–	0.05%	293
2020 Q4	$285K	Hold	10,905	–	–	0.06%	256
2020 Q3	$190K	Hold	10,905	–	–	0.04%	294
2020 Q2	$183K	Hold	10,905	–	–	0.04%	327
2020 Q1	$130K	Hold	10,905	–	–	0.04%	334
2019 Q4	$132K	Hold	10,905	–	–	0.03%	368
2019 Q3	$154K	Hold	10,905	–	–	0.05%	357
2019 Q2	$122K	Hold	10,905	–	–	0.04%	376
2019 Q1	$128K	Hold	10,905	–	–	0.05%	330
2018 Q4	$146K	Hold	10,905	–	–	0.06%	296
2018 Q3	$158K	Hold	10,905	–	–	0.05%	312
2018 Q2	$152K	Buy	10,905 +905	+9%	+$15.7K	0.05%	300
2018 Q1	$165K	Buy	+10,000	New	+$185K	0.05%	297